EU paediatric studies: can fines succeed where carrots and sticks have not?
This article was originally published in SRA
Executive Summary
Few would deny that the EU regulation on paediatric medicines has achieved a degree of success in getting more drugs tested and approved for use in children. Many, however, would question whether enough progress has been made.